BECONASE AQ is a Nasal Spray, Suspension in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Beclomethasone Dipropionate Monohydrate.
Product ID | 0173-0388_26e3064c-0f19-477e-8b0a-0030854edbfd |
NDC | 0173-0388 |
Product Type | Human Prescription Drug |
Proprietary Name | BECONASE AQ |
Generic Name | Beclomethasone Dipropionate Monohydrate |
Dosage Form | Spray, Suspension |
Route of Administration | NASAL |
Marketing Start Date | 1989-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA019389 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | BECLOMETHASONE DIPROPIONATE MONOHYDRATE |
Active Ingredient Strength | 42 ug/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1989-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019389 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 1989-10-01 |
Ingredient | Strength |
---|---|
BECLOMETHASONE DIPROPIONATE MONOHYDRATE | 42 ug/1 |
SPL SET ID: | a44782cf-4ab5-4c8a-79b7-221f21e40a34 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BECONASE 73123070 1087982 Dead/Expired |
ALLEN & HANBURYS LIMITED 1977-04-18 |